Gene therapy developer Orchard Therapeutics raises $110 million

(Reuters) - Orchard Therapeutics said on Wednesday it raised $110 million in the second round of funding as the drug developer looks to launch its gene therapy to treat a rare inherited disorder and beef up manufacturing facilities.